Sofinnova Investments’s Mirum Pharmaceuticals MIRM Stock Holding History

Sofinnova Investments’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.55M	Buy	27,591 +4,491	+19%	+$422K	0.1%	61
2025 Q4	$1.82M	Buy	+23,100	New	+$1.66M	0.08%	55
2024 Q2	–	Sell	-3,012	Closed	-$75.7K	–	86
2024 Q1	$75.7K	Sell	3,012 -349,385	-99%	-$9.61M	﹤0.01%	72
2023 Q4	$10.4M	Buy	352,397 +343,308	+3,777%	+$10.4M	0.58%	34
2023 Q3	$287K	Hold	9,089	–	–	0.02%	63
2023 Q2	$235K	Buy	+9,089	New	+$242K	0.02%	51
2021 Q3	–	Sell	-259,465	Closed	-$4.49M	–	80
2021 Q2	$4.49M	Sell	259,465 -216,936	-46%	-$3.89M	0.26%	53
2021 Q1	$9.44M	Buy	476,401 +21,427	+5%	+$410K	0.57%	37
2020 Q4	$7.94M	Buy	454,974 +133,722	+42%	+$2.63M	0.47%	41
2020 Q3	$6.19M	Sell	321,252 -220,449	-41%	-$4.73M	0.46%	42
2020 Q2	$10.5M	Buy	541,701 +123,112	+29%	+$2.06M	0.66%	35
2020 Q1	$5.86M	Buy	+418,589	New	+$6.87M	0.54%	31

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Sofinnova Investments's MIRM Position: Q1 2026 in Review

Sofinnova Investments increased its Mirum Pharmaceuticals (MIRM) stake by 19% in Q1 2026, buying an estimated $422K and bringing the position to 27,591 shares worth $2.55M. The position accounts for 0.1% of the portfolio, ranked #61.

Sofinnova Investments first reported a position in MIRM in Q1 2020 and has held it in 12 quarters since. The position peaked at $10.5M in Q2 2020. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

Sofinnova Investments held 27,591 shares of Mirum Pharmaceuticals worth $2.55M as of Q1 2026.
Sofinnova Investments bought 4,491 Mirum Pharmaceuticals shares in Q1 2026, an estimated $422K.
Mirum Pharmaceuticals made up 0.1% of Sofinnova Investments's portfolio in Q1 2026, its #61 holding.
Sofinnova Investments first reported a position in Mirum Pharmaceuticals in Q1 2020 and has held it in 12 quarters since.
Sofinnova Investments's Mirum Pharmaceuticals position peaked at $10.5M in Q2 2020.
311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Sofinnova Investments's 13F filing for Q1 2026, filed 15 May 2026.